June put us into the 6th month since the genome of the new coronavirus was sequenced and made available to the world. That basically fired the starting gun for the race to a vaccine: 12 to 18 months, was the fastest it could take, we've been told. My overview post for the status as the 6th month began, at Absolutely Maybe – Covid-19 Vaccine Race, Month 6: First Emergency Use & Phase 3 Trials. And then another, on those at phase 3 trial stage, through the lens of those trials and the interim results of their earlier trials: The Clinical Trial Results Stampede Begins: Covid-19 Vaccine Race, Month 7.

Also on Covid-19 vaccines: my thoughts about the dangers of misleading and unchallenged marketing hype about their adverse effects, at WIRED. (And I go into the ethics and evidence on this in the above "Month 7" post.)

Also at Absolutely Maybe, thoughts on a hyped observational study of hydroxychloroquine for Covid-19: Study Publications Must Be Up-To-Date in Covid Time.

It's a Covid-19 theory that went viral: women leaders were handling the pandemic better than their male counterparts. Now, I've got Jacinda-Ardern-envy, too, but I think this is a bias bonfire. I explain why at WIRED: What the data really says about women leaders and the pandemic.

After a bit of popular demand, I wrote a post about the Ioannidis debates, at Absolutely Maybe: Science Heroes and Disillusion.

And I was on the Australian Medical Students' Association podcast, talking with Daryl Goh, Adam Dunn, and Kieran Kennedy on misinformation in health (71 minutes on Spotify).





My latest at WIRED is a dig into a complicated question: Social Distancing Has Become the Norm. What Have We Learned? 

A post I was working on before Covid-19. In which I point to 3 ways conflict of interest claims get twisted like pretzels. Absolutely Maybe: A Cartoon Guide to Conflict of Interest Claims, Fair & Foul. A lot of words, but also cartoons! And a second one that had its start pre-pandemic: Let's Be Serious About Bias in Protocols for Systematic Reviews.

John Ioannidis published a preprint concluded Covid-19 has a low infection fatality rate (IFR), and it was March all over again for me: I couldn't concentrate on anything else. So here's my take: A Critical Look at a Preprint Inferring the Covid-19 Infection Fatality Rate. It turned into a trilogy...

Part 2 was A Critical Look at Preprints on Covid-19 Infection Fatality Rates:The Sequel - considering another 2 preprints besides the Ioannidis one.

Part 3 was at Absolutely Maybe. After wrestling with the severe problems in a couple of those preprints, I nevertheless decided to write Reasons to Worry Less the Explosion of Preprints.

And in other news, the US National Information Standards Organization has a document on standardizing badges at journals out for consultation. I submitted a comment challenging doing this at all.






My first contribution to WIRED: The Face Mask Debate Reveals a Scientific Double Standard. Healthcare and other essential workers are absolutely the priority, but that doesn't mean they couldn't play a role in reducing the pandemic's spread.

And I wrote a post on the evidence about masks to prevent the spread of infection at Absolutely Maybe: The Limits of Those Reviews of Masks For All and What We Do Know.

And my first editorial in the Drugs and Therapeutics Bulletin: Improving consultations with children and adolescents.






Where on earth did those "top 5 regrets of the dying" come from, and why do people believe it? In which I get fascinated by the research on regret, discover that people can be "regret averse" (and I am!). At Absolutely Maybe: Why Do Scientists "Cite" the Top 5 Regrets of the Dying?

#ThrowbackThursday: With COVID-19's arrival, I updated my 2014 post on "the Dracula sneeze" in case anyone should land on it. Just as well, too - CDC links were broken and the evidence I'd cited was very out-of-date. Still shocked, though, that there hasn't been more evidence.

There has been stunningly fast progress, though, on a vaccine for COVID-19. And I tackled that and the clinical trial phase process in my post, First in Human: COVID-19 Vaccines & Tales of Phase 1 Clinical Trials Past.

Also on the coronavirus pandemic, I vented on an opinion piece by John Ioannidis: A Rebuttal to "A Fiasco in the Making?" - and dug into data further in a follow-up post, "Fiasco" Rebuttal Postscript: What About That 0.3% Fatality Estimate?

Cochrane published the first progress report for the update of the Cochrane review on exercise and ME/CFS, with a new "home" for news about it.





Honored to be leading an independent advisory group for the full update of the Cochrane review on exercise therapy and ME/CFS. I'm so happy to see community concerns taken this seriously. More details, including a contact emails for the group, in the Cochrane announcement.

Also on the subject of the Cochrane Collaboration, I posted a timeline and thoughts in the aftermath of Peter Gøtzsche's expulsion from the organization: here.

The month is ending with the publication of the systematic review of the HPV vaccines by Jørgensen, Gøtzsche, and Jefferson. I was invited to write the commentary accompanying it, here at Systematic Reviews. I've blogged about it at Absolutely Maybe: The High Risk Methods of New Systematic Review of HPV Vaccines.

And for Black History Month, I focused on African-American chemists and a fabulous sociologist who studied them. On Wikipedia, I created an article on the sociologist, Willie Pearson Jr, uploading a photo that I took of him as well. And when I saw that the Wikipedia page for one of the towering African-American figures in chemistry, Samuel P. Massie, was just a paragraph, with no photo, I tackled that one too. Here's my post at Absolutely Maybe:

Black History Month: Chemists' Powerful Stories and the Sociologist Who Studied Them.

This photo below of the chemistry lab at Howard University around 1900 is one that was curated by another sociologist, the remarkable W.E.B. DuBois. But you can read about that in the post!






Find me on: